Published in ISRN Oncol on June 21, 2012
Matrix-producing carcinoma of the breast: a case report. Case Rep Oncol (2013) 0.86
Rare breast tumors: Review of the literature. Rep Pract Oncol Radiother (2013) 0.81
Breast Carcinosarcomas. J Breast Health (2013) (2014) 0.75
Metaplastic Carcinoma of Breast with Extensive Chondroid Differentiation: A Case Report with Review of Literature. J Clin Diagn Res (2015) 0.75
A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin. Cureus (2016) 0.75
Metaplastic Breast Carcinoma: Analysis of Clinical and Pathologic Characteristics - A Case Series. J Breast Health (2013) (2016) 0.75
Paraneoplastic polymyositis presenting as a clinically occult breast cancer. Ann R Coll Surg Engl (2016) 0.75
Rare Malignant Tumors of the Breast. J Clin Imaging Sci (2015) 0.75
A case of metaplastic breast cancer in a man. J Surg Case Rep (2013) 0.75
Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast. Oncol Lett (2017) 0.75
Metaplastic Carcinoma Breast: A Clinical Analysis of Nine Cases. J Clin Diagn Res (2017) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA (2011) 16.68
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res (2007) 11.56
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med (1997) 7.61
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer (2003) 2.77
Metaplastic breast cancer: clinical significance. Am J Surg (2006) 2.41
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer (2004) 2.29
Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol (2006) 2.23
Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol (1989) 2.22
Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol (1999) 2.12
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat (2006) 1.99
Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol (2006) 1.91
Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer (1989) 1.89
Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol (1989) 1.86
Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol (1987) 1.66
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg (1995) 1.66
Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol (1990) 1.62
Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer (1990) 1.57
Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol (2005) 1.55
Metaplastic breast cancer: clinical features and outcomes. Am Surg (2005) 1.44
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. Breast Cancer Res Treat (2011) 1.36
Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat (2005) 1.33
Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol (2010) 1.33
Classification of metaplastic carcinomas of the breast. Pathol Annu (1992) 1.28
Metaplastic carcinoma of the breast: a retrospective review. Int J Radiat Oncol Biol Phys (2005) 1.24
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol (1988) 1.02
A case of metaplastic carcinoma of the breast responsive to chemotherapy with Ifosfamide and Etoposide: improved antitumor response by targeting sarcomatous features. Breast J (2010) 0.88
The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence. Am J Surg (2008) 1.71
Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med (2009) 1.68
Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol (2008) 1.66
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg (2013) 1.47
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol (2005) 1.40
Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy. Neuro Oncol (2002) 1.36
Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol (2010) 1.33
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res (2006) 1.32
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg (2006) 1.31
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res (2007) 1.19
Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res (2006) 1.18
Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg (2011) 1.17
The role of surgery in treatment of stage IV melanoma. J Surg Oncol (2006) 1.17
Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem (2009) 1.14
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol (2012) 1.11
The clinical significance of MAGEA3 expression in pancreatic cancer. Int J Cancer (2006) 1.11
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res (2009) 1.11
Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res (2010) 1.10
Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg (2009) 1.10
Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol (2010) 1.08
An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg (2010) 1.05
Sentinel lymph node mapping with GI cancer. Cancer Metastasis Rev (2006) 1.05
Metastatic melanoma - a review of current and future treatment options. Acta Derm Venereol (2015) 1.05
Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol (2010) 1.03
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma Res (2011) 1.03
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg (2011) 0.99
P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy. Hum Pathol (2012) 0.91
Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma. J Surg Res (2010) 0.90
Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis. Cancer Res (2006) 0.89
Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res (2011) 0.88
Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) (2013) 0.87
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res (2012) 0.86
Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg (2010) 0.86
Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol (2010) 0.86
Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol (2011) 0.85
Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res (2011) 0.85
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol (2010) 0.85
Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. J Surg Oncol (2013) 0.84
Outcomes for lymph node-positive cutaneous melanoma over two decades. World J Surg (2011) 0.83
Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg (2013) 0.82
Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer (2011) 0.80
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes? Cancer J (2006) 0.78
Rural-urban disparities in use of post-lumpectomy radiation. Med Oncol (2012) 0.78
Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol (2011) 0.77
Extremity soft tissue tumor surgery by surgical specialty: a comparison of case volume among oncology and non-oncology-designated surgeons. J Surg Oncol (2013) 0.77
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring? Rare Tumors (2013) 0.77
Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis. J Surg Res (2013) 0.76
Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol (2012) 0.75
Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient care. J Surg Educ (2012) 0.75
Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res (2012) 0.75
Novel effective drugs and evolving ablation technology: a more comprehensive approach to hepatic malignancies. Ann Surg Oncol (2004) 0.75
Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma. J Surg Res (2013) 0.75